Topical nasal lysine aspirin in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis with nasal polyposis

Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease

(2013) K. Fruth et al.   ALLERGY

Aspirin 300 mg/day is effective for treating aspirin-exacerbated respiratory disease

(2013) S. Comert et al.   ALLERGY

Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs

(2013) M. L. Kowalski et al.   ALLERGY

Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding

(2013) Steven R. Steinhubl   ANNALS OF INTERNAL MEDICINE

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease

(2013) B. Miller et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad

(2012) Miriam Havel et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Herpes Simplex Virus Type 1 Infection Facilitates Invasion of Staphylococcus aureus into the Nasal Mucosa and Nasal Polyp Tissue

(2012) XiangDong Wang et al.   PLoS One

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

(2010) Peter M Rothwell et al.   LANCET

Aspirin-Exacerbated Respiratory Disease: Evaluation and Management

(2010) Rachel U. Lee et al.   Allergy Asthma & Immunology Research

Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily

(2008) A. Rozsasi et al.   ALLERGY